Trial intelligence / Profile preview

SVF-enriched Facial Fat Grafts for Facial Atrophy

NCT02526576Phase 2Completed

Sponsor
Antria, Inc.
Start
Aug 2015
Primary completion
Jul 2017
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous adipose stromal vascular fraction in Parry-Romberg syndrome (PRS), sponsored by Antria, Inc.. Started Aug 2015; status: completed.

02

Drugs

autologous adipose stromal vascular fraction
03

Conditions

Parry-Romberg syndrome (PRS)

Beyond the preview

Go deeper on NCT02526576.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02526576.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call